Andrew Knudten

Andrew Knudten

No open positions remaining
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Andrew Knudten is a Chief Operating Officer at Jaguar Gene Therapy LLC and a Chief Technical Officer at Cirius Therapeutics, Inc. Mr. Knudten was previously employed as a Chief Technical Officer & SVP-Technical Operations by AveXis, Inc., a Vice President-Operations & Plant Manager by Hospira, Inc., a Global Head-Contract Manufacturing by Novartis AG, a Vice President-Manufacturing by CoDa Therapeutics, Inc., and an Operations Director by Amgen, Inc. He received his undergraduate degree from Concordia University, a graduate degree from the University of Nebraska and an MBA from UCLA Anderson School of Management.

Andrew Knudten active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 02/06/2019
Chief Operating Officer 31/01/2020

Former positions of Andrew Knudten

CompaniesPositionEnd
HOSPIRA, INC. Corporate Officer/Principal 31/08/2015
NOVARTIS AG Corporate Officer/Principal 29/02/2012
Corporate Officer/Principal 31/01/2009
AMGEN INC. Chief Operating Officer 31/12/2006
AVEXIS INC Chief Tech/Sci/R&D Officer -
See the detail of Andrew Knudten's experience

Training of Andrew Knudten

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

  1. Stock Market
  2. Insiders
  3. Andrew Knudten